The R-enantiomer of ketorolac reduces ovarian cancer tumor burden in vivo. Grimes MM, Kenney SR, Dominguez DR, Brayer KJ, et al. BMC Cancer 2021;21:40.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Grimes MM, Kenney SR, Dominguez DR, Brayer KJ, et al. The R-enantiomer of ketorolac reduces ovarian cancer tumor burden in vivo. BMC Cancer 2021;21:40.
PMID: 33413202